Matches in SemOpenAlex for { <https://semopenalex.org/work/W2989806528> ?p ?o ?g. }
Showing items 1 to 80 of
80
with 100 items per page.
- W2989806528 endingPage "4697" @default.
- W2989806528 startingPage "4688" @default.
- W2989806528 abstract "To elucidate the effects and mechanism of microRNA-23b (miR-23b) in cervical cancer (CC) progression.Fifty-six pairs of CC tissue samples and matched para-carcinoma tissue samples were collected. Meanwhile, human normal cervical epithelial cell and CC cell lines were cultured. The abilities of cell proliferation and migration were detected by 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assays and transwell assays. The correlation between sine oculis homeobox 1 (six1) and miR-23b was clarified by dual-luciferase reporter assay. The relative protein and mRNA expression were detected by quantitative real-time polymerase chain reaction (qRT-PCR), immunohistochemistry (IHC) and Western blot. In addition, Xenograft tumor formation assay was performed in this study.MiR-23b was remarkably down-regulated in CC and the low miR-23b expressions were associated with the poor prognosis and worse OS of CC patients. Additionally, the functional assays demonstrated that miR-23b overexpression obviously repressed CC cell proliferation, invasion and migration abilities through the regulation of the AKT/mTOR pathway and the epithelial-to-mesenchymal transition (EMT) progress. Moreover, the luciferase reporter assay indicated that six1 was one functional target for miR-23b in CC cells, indicating that the inhibitory functions of miR-23b in CC cells were partially regulated by six1. Moreover, miR-23b restoration could prominently repress tumor growth in vivo.MiR-23b suppressed CC progression via directly targeting six1 and affecting AKT/mTOR signaling pathway as well as EMT progress. Therefore, miR-23b/six1 may be promising biomarkers for CC diagnosis and therapy." @default.
- W2989806528 created "2019-12-05" @default.
- W2989806528 creator A5007383289 @default.
- W2989806528 creator A5019560610 @default.
- W2989806528 creator A5053354230 @default.
- W2989806528 creator A5079281768 @default.
- W2989806528 creator A5085788510 @default.
- W2989806528 date "2019-06-01" @default.
- W2989806528 modified "2023-09-23" @default.
- W2989806528 title "MicroRNA-23b suppresses cervical cancer biological progression by directly targeting six1 and affecting epithelial-to-mesenchymal transition and AKT/mTOR signaling pathway." @default.
- W2989806528 doi "https://doi.org/10.26355/eurrev_201906_18050" @default.
- W2989806528 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31210295" @default.
- W2989806528 hasPublicationYear "2019" @default.
- W2989806528 type Work @default.
- W2989806528 sameAs 2989806528 @default.
- W2989806528 citedByCount "5" @default.
- W2989806528 countsByYear W29898065282021 @default.
- W2989806528 countsByYear W29898065282022 @default.
- W2989806528 countsByYear W29898065282023 @default.
- W2989806528 crossrefType "journal-article" @default.
- W2989806528 hasAuthorship W2989806528A5007383289 @default.
- W2989806528 hasAuthorship W2989806528A5019560610 @default.
- W2989806528 hasAuthorship W2989806528A5053354230 @default.
- W2989806528 hasAuthorship W2989806528A5079281768 @default.
- W2989806528 hasAuthorship W2989806528A5085788510 @default.
- W2989806528 hasConcept C104317684 @default.
- W2989806528 hasConcept C127561419 @default.
- W2989806528 hasConcept C137738243 @default.
- W2989806528 hasConcept C145059251 @default.
- W2989806528 hasConcept C1491633281 @default.
- W2989806528 hasConcept C153911025 @default.
- W2989806528 hasConcept C185592680 @default.
- W2989806528 hasConcept C2776415932 @default.
- W2989806528 hasConcept C502942594 @default.
- W2989806528 hasConcept C55493867 @default.
- W2989806528 hasConcept C62112901 @default.
- W2989806528 hasConcept C62478195 @default.
- W2989806528 hasConcept C75217442 @default.
- W2989806528 hasConcept C76419328 @default.
- W2989806528 hasConcept C86554907 @default.
- W2989806528 hasConcept C86803240 @default.
- W2989806528 hasConcept C95444343 @default.
- W2989806528 hasConceptScore W2989806528C104317684 @default.
- W2989806528 hasConceptScore W2989806528C127561419 @default.
- W2989806528 hasConceptScore W2989806528C137738243 @default.
- W2989806528 hasConceptScore W2989806528C145059251 @default.
- W2989806528 hasConceptScore W2989806528C1491633281 @default.
- W2989806528 hasConceptScore W2989806528C153911025 @default.
- W2989806528 hasConceptScore W2989806528C185592680 @default.
- W2989806528 hasConceptScore W2989806528C2776415932 @default.
- W2989806528 hasConceptScore W2989806528C502942594 @default.
- W2989806528 hasConceptScore W2989806528C55493867 @default.
- W2989806528 hasConceptScore W2989806528C62112901 @default.
- W2989806528 hasConceptScore W2989806528C62478195 @default.
- W2989806528 hasConceptScore W2989806528C75217442 @default.
- W2989806528 hasConceptScore W2989806528C76419328 @default.
- W2989806528 hasConceptScore W2989806528C86554907 @default.
- W2989806528 hasConceptScore W2989806528C86803240 @default.
- W2989806528 hasConceptScore W2989806528C95444343 @default.
- W2989806528 hasIssue "11" @default.
- W2989806528 hasLocation W29898065281 @default.
- W2989806528 hasOpenAccess W2989806528 @default.
- W2989806528 hasPrimaryLocation W29898065281 @default.
- W2989806528 hasRelatedWork W1976679129 @default.
- W2989806528 hasRelatedWork W2037440964 @default.
- W2989806528 hasRelatedWork W2132283968 @default.
- W2989806528 hasRelatedWork W2438578109 @default.
- W2989806528 hasRelatedWork W2769123435 @default.
- W2989806528 hasRelatedWork W2936298816 @default.
- W2989806528 hasRelatedWork W2939274558 @default.
- W2989806528 hasRelatedWork W2948341381 @default.
- W2989806528 hasRelatedWork W3153105942 @default.
- W2989806528 hasRelatedWork W3164029683 @default.
- W2989806528 hasVolume "23" @default.
- W2989806528 isParatext "false" @default.
- W2989806528 isRetracted "false" @default.
- W2989806528 magId "2989806528" @default.
- W2989806528 workType "article" @default.